Filters
Other countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
KCNJ11 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 5 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 669 | 688 |
|
Labcorp Genetics (formerly Invitae) LabCorp United States | 173 | 119 |
|
Invitae Monogenic Diabetes Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 59 | 28 |
|
PreventionGenetics, part of Exact Sciences United States | 101 | 54 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Invitae Comprehensive Carrier Screen Labcorp Genetics (formerly Invitae) LabCorp United States | 886 | 547 |
|
Translational Metabolic Laboratory Radboud University Medical Centre Netherlands | 4 | 1 |
|
Dyslipidemia and early atherosclerosis panel. 84-gene NGS panel. Genologica Medica Spain | 133 | 84 |
|
MODY type diabetes panel. NGS panel of 13 genes. Genologica Medica Spain | 29 | 13 |
|
Comprehensive panel of monogenic diabetes. 28-gene NGS panel. Genologica Medica Spain | 60 | 28 |
|
Hypoglycemia, hyperinsulinism, and ketone metabolism panel. NGS panel of 50 genes. Genologica Medica Spain | 73 | 50 |
|
Diabetes mellitus: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 12 | 10 |
|
Duzen Laboratories Duzen BBAGUAS Turkey | 4 | 1 |
|
Maturity onset diabetes of the young (MODY) panel Al Jalila Children’s Genomics Center Al Jalila Childrens Speciality Hospital United Arab Emirates | 15 | 17 |
|
Al Jalila Children’s Genomics Center Al Jalila Childrens Speciality Hospital United Arab Emirates | 11 | 13 |
|
Comprehensive Metabolism NGS Panel Fulgent Genetics United States | 602 | 355 |
|
Fulgent Genetics United States | 509 | 275 |
|
Expanded Polycystic Kidney Disease NGS Panel Fulgent Genetics United States | 61 | 34 |
|
Fulgent Genetics United States | 71 | 53 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.